State of Wyoming’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Buy
+3,914
New +$204K 0.02% 945
2026
Q1
Sell
-10,310
Closed -$398K 1999
2025
Q4
$398K Sell
10,310
-904
-8% -$34.5K 0.04% 528
2025
Q3
$396K Sell
11,214
-222
-2% -$8.04K 0.05% 491
2025
Q2
$412K Sell
11,436
-8
-0.1% -$265 0.05% 410
2025
Q1
$356K Sell
11,444
-3,652
-24% -$116K 0.05% 430
2024
Q4
$385K Buy
15,096
+8,518
+129% +$226K 0.05% 398
2024
Q3
$186K Sell
6,578
-223
-3% -$6.18K 0.03% 766
2024
Q2
$179K Buy
+6,801
New +$189K 0.03% 657
2024
Q1
Sell
-6,612
Closed -$186K 1797
2023
Q4
$186K Buy
6,612
+626
+10% +$17.2K 0.03% 609
2023
Q3
$162K Sell
5,986
-432
-7% -$12.8K 0.04% 602
2023
Q2
$197K Buy
6,418
+636
+11% +$21.5K 0.06% 395
2023
Q1
$208K Buy
+5,782
New +$214K 0.07% 311
2022
Q4
Sell
-2,243
Closed -$90K 1732
2022
Q3
$90K Sell
2,243
-30
-1% -$1.28K 0.04% 666
2022
Q2
$96K Buy
+2,273
New +$93.2K 0.06% 527
2022
Q1
Sell
-2,243
Closed -$89K 1992
2021
Q4
$89K Buy
2,243
+512
+30% +$19.9K 0.04% 729
2021
Q3
$63K Buy
+1,731
New +$67.3K 0.04% 673

Other funds holding RPRX

State of Wyoming's RPRX Position: Q2 2026 in Review

State of Wyoming opened a new position in Royalty Pharma (RPRX) in Q2 2026: 3,914 shares worth $219K. The stake represents 0.02% of the portfolio and ranks #945 among its holdings. This is a return to the name: State of Wyoming previously reported a position in RPRX as recently as Q4 2025.

State of Wyoming first reported a position in RPRX in Q3 2021 and has held it in 16 quarters since. The position peaked at $412K in Q2 2025. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • State of Wyoming held 3,914 shares of Royalty Pharma worth $219K as of Q2 2026.
  • Royalty Pharma was a new State of Wyoming position in Q2 2026.
  • Royalty Pharma made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #945 holding.
  • State of Wyoming first reported a position in Royalty Pharma in Q3 2021 and has held it in 16 quarters since.
  • State of Wyoming's Royalty Pharma position peaked at $412K in Q2 2025.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.